These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 23704133)

  • 1. Development of a pharmacodynamic assay based on PLCγ2 phosphorylation for quantifying spleen tyrosine kinase (SYK)-Bruton's tyrosine kinase (BTK) signaling.
    Hsu J; Zhang J; Kitson C; Tan SL; Narula S; DeMartino JA; Liao C
    J Biomol Screen; 2013 Sep; 18(8):890-8. PubMed ID: 23704133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bruton's Tyrosine Kinase mediates platelet receptor-induced generation of microparticles: a potential mechanism for amplification of inflammatory responses in rheumatoid arthritis synovial joints.
    Hsu J; Gu Y; Tan SL; Narula S; DeMartino JA; Liao C
    Immunol Lett; 2013 Feb; 150(1-2):97-104. PubMed ID: 23266841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential Regulation of GPVI-Induced Btk and Syk Activation by PKC, PKA and PP2A in Human Platelets.
    Zhang P; Solari FA; Heemskerk JWM; Kuijpers MJE; Sickmann A; Walter U; Jurk K
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the effects of Syk and BTK inhibitors on GPVI-mediated platelet signaling and function.
    Zheng TJ; Lofurno ER; Melrose AR; Lakshmanan HHS; Pang J; Phillips KG; Fallon ME; Kohs TCL; Ngo ATP; Shatzel JJ; Hinds MT; McCarty OJT; Aslan JE
    Am J Physiol Cell Physiol; 2021 May; 320(5):C902-C915. PubMed ID: 33689480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of CD19 Y484 and Y515, and linked activation of phosphatidylinositol 3-kinase, are required for B cell antigen receptor-mediated activation of Bruton's tyrosine kinase.
    Buhl AM; Cambier JC
    J Immunol; 1999 Apr; 162(8):4438-46. PubMed ID: 10201980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the SYK-BTK axis for the treatment of immunological and hematological disorders: recent progress and therapeutic perspectives.
    Tan SL; Liao C; Lucas MC; Stevenson C; DeMartino JA
    Pharmacol Ther; 2013 May; 138(2):294-309. PubMed ID: 23396081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin inhibits GPVI-mediated platelet activation by interfering with the kinase activity of Syk and the subsequent activation of PLCgamma2.
    Mayanglambam A; Dangelmaier CA; Thomas D; Damodar Reddy C; Daniel JL; Kunapuli SP
    Platelets; 2010; 21(3):211-20. PubMed ID: 20158382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for Bruton's tyrosine kinase (Btk) in platelet activation by collagen.
    Quek LS; Bolen J; Watson SP
    Curr Biol; 1998 Oct; 8(20):1137-40. PubMed ID: 9778529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Swiprosin-1/EFhd2 controls B cell receptor signaling through the assembly of the B cell receptor, Syk, and phospholipase C gamma2 in membrane rafts.
    Kroczek C; Lang C; Brachs S; Grohmann M; Dütting S; Schweizer A; Nitschke L; Feller SM; Jäck HM; Mielenz D
    J Immunol; 2010 Apr; 184(7):3665-76. PubMed ID: 20194721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrosine phosphorylation on spleen tyrosine kinase (Syk) is differentially regulated in human and murine platelets by protein kinase C isoforms.
    Buitrago L; Bhavanasi D; Dangelmaier C; Manne BK; Badolia R; Borgognone A; Tsygankov AY; McKenzie SE; Kunapuli SP
    J Biol Chem; 2013 Oct; 288(40):29160-9. PubMed ID: 23960082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noncatalytic Bruton's tyrosine kinase activates PLCγ
    Wist M; Meier L; Gutman O; Haas J; Endres S; Zhou Y; Rösler R; Wiese S; Stilgenbauer S; Hobeika E; Henis YI; Gierschik P; Walliser C
    J Biol Chem; 2020 Apr; 295(17):5717-5736. PubMed ID: 32184360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bruton's tyrosine kinase is essential for hydrogen peroxide-induced calcium signaling.
    Qin S; Chock PB
    Biochemistry; 2001 Jul; 40(27):8085-91. PubMed ID: 11434777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The alpha2beta1 integrin is a necessary co-receptor for collagen-induced activation of Syk and the subsequent phosphorylation of phospholipase Cgamma2 in platelets.
    Keely PJ; Parise LV
    J Biol Chem; 1996 Oct; 271(43):26668-76. PubMed ID: 8900143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The toll-like receptor 2/1 (TLR2/1) complex initiates human platelet activation via the src/Syk/LAT/PLCγ2 signalling cascade.
    Fälker K; Klarström-Engström K; Bengtsson T; Lindahl TL; Grenegård M
    Cell Signal; 2014 Feb; 26(2):279-86. PubMed ID: 24240055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bruton's tyrosine kinase inhibition induces rewiring of proximal and distal B-cell receptor signaling in mice.
    Rip J; de Bruijn MJW; Neys SFH; Singh SP; Willar J; van Hulst JAC; Hendriks RW; Corneth OBJ
    Eur J Immunol; 2021 Sep; 51(9):2251-2265. PubMed ID: 34323286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting spleen tyrosine kinase-Bruton's tyrosine kinase axis for immunologically mediated glomerulonephritis.
    Chen JS; Chang LC; Huang SJ; Cheng CW
    Biomed Res Int; 2014; 2014():814869. PubMed ID: 24795896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Four tyrosine residues in phospholipase C-gamma 2, identified as Btk-dependent phosphorylation sites, are required for B cell antigen receptor-coupled calcium signaling.
    Watanabe D; Hashimoto S; Ishiai M; Matsushita M; Baba Y; Kishimoto T; Kurosaki T; Tsukada S
    J Biol Chem; 2001 Oct; 276(42):38595-601. PubMed ID: 11507089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of lyn, blk, and btk but not syk in CD72-stimulated B lymphocytes.
    Venkataraman C; Muthusamy N; Muthukkumar S; Bondada S
    J Immunol; 1998 Apr; 160(7):3322-9. PubMed ID: 9531290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paired immunoglobulin-like receptor B (PIR-B) inhibits BCR-induced activation of Syk and Btk by SHP-1.
    Maeda A; Scharenberg AM; Tsukada S; Bolen JB; Kinet JP; Kurosaki T
    Oncogene; 1999 Apr; 18(14):2291-7. PubMed ID: 10327049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct pathways regulate Syk protein activation downstream of immune tyrosine activation motif (ITAM) and hemITAM receptors in platelets.
    Manne BK; Badolia R; Dangelmaier C; Eble JA; Ellmeier W; Kahn M; Kunapuli SP
    J Biol Chem; 2015 May; 290(18):11557-68. PubMed ID: 25767114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.